Zobrazeno 1 - 10
of 42
pro vyhledávání: '"T. M. Pramod Kumar"'
Autor:
Rosy Raju, Sunitha Chandrashekar Srinivas, Srikanth Malavalli Siddalingegowda, Raj Vaidya, Manjiri Gharat, T. M. Pramod Kumar
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 27 (2024)
Antimicrobial resistance (AMR) is a global public health crisis that impedes the therapeutic effectiveness of available antimicrobial agents. Due to the high burden of infectious diseases and limited resources, especially trained healthcare professio
Externí odkaz:
https://doaj.org/article/7e0a7c9f6f134a2bbdb403e231d3616d
Autor:
M. P. Gowrav, K. G. Siree, T. M. Amulya, M. B. Bharathi, Mohammed Ghazwani, Ali Alamri, Abdulatef Y. Alalkami, T. M. Pramod Kumar, Mohammed Muqtader Ahmed, Mohamed Rahamathulla
Publikováno v:
Polymers, Vol 15, Iss 11, p 2521 (2023)
A novel approach to the treatment of sinusitis is the use of nasal stents. The stent is loaded with a corticosteroid, which prevents complications in the wound-healing process. The design is such that it will prevent the sinus from closing again. The
Externí odkaz:
https://doaj.org/article/c75dc66c16f3491e900d312da67e6078
Autor:
M. P. Gowrav, B. G. Ramu, K. Divith, S. Sowmya, T. M. Pramod Kumar, T. M. Amulya, K. G. Siree
Publikováno v:
Journal of Pharmaceutical Research International. :207-218
Three-dimensional (3D) printing is a unique technique that allows for a high degree of customisation in pharmacy, dentistry and in designing of medical devices. 3D printing satiates the increasing exigency for consumer personalisation in these fields
Autor:
M. P. Gowrav, Gorthi Nihar, K. Divith, M. B. Bharathi, T. M. Pramod Kumar, K. G. Siree, T. M. Amulya
Publikováno v:
Journal of Pharmaceutical Research International. :52-64
The scope and applications of biomaterials have spread out throughout a broad spectrum. Particularly in pharmacy, biomaterials are an attractive choice because they can be modified to decrease toxicity, increase the targeting ability among many other
Publikováno v:
RESEARCH JOURNAL OF PHARMACY AND TECHNOLOGY. 14:1785-1790
Publikováno v:
Applied Clinical Research, Clinical Trials and Regulatory Affairs. 7:93-103
The pharmaceutical industry is developed every year with the aim of public health, safety, and financial growth. Keeping public safety in mind, the industry is mostly concentrated on novel plans in the drug development process and plans on how to inc
Publikováno v:
INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE. 11:350-354
Regenerative medicine is a new and expanding field in biomedical research. Organ and tissue loss through disease and injury, propel the development of a treatment that can regenerate tissue and help for less relaying in organ transplantation. Regener
Autor:
Akash Dambal, Kaushik Devaraju, T. M. Pramod Kumar, Madhugiri Prakash Venkatesh, Harrison Michael Zaphrey
Publikováno v:
INTERNATIONAL JOURNAL OF PHARMACEUTICAL QUALITY ASSURANCE. 11:186-192
FDA’s Center for Devices and Radiological Health (CDRH) is responsible for regulating firms who manufacture, repackage, relabel, and/or import medical devices sold in the United States. Regulatory control increases from class I to III. Most class I
Publikováno v:
International Research Journal Of Pharmacy. 11:6-11
Publikováno v:
Critical Reviews™ in Therapeutic Drug Carrier Systems. 36:485-536
Rheumatoid arthritis (RA) is a debilitating condition that results in impairment of joints and ligaments and thus constrained mobility and decreased array of movement. It is a broad expression that encompasses additional 100 very diverse disorders ma